Bacillus coagulans MTCC 5856 for the management of major depression with irritable bowel syndrome: a randomised, double-blind, placebo controlled, multi-centre, pilot clinical study.
about
Bacillus coagulans MTCC 5856 for the management of major depression with irritable bowel syndrome: a randomised, double-blind, placebo controlled, multi-centre, pilot clinical study.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Bacillus coagulans MTCC 5856 f ...... -centre, pilot clinical study.
@en
Bacillus coagulans MTCC 5856 f ...... -centre, pilot clinical study.
@nl
type
label
Bacillus coagulans MTCC 5856 f ...... -centre, pilot clinical study.
@en
Bacillus coagulans MTCC 5856 f ...... -centre, pilot clinical study.
@nl
prefLabel
Bacillus coagulans MTCC 5856 f ...... -centre, pilot clinical study.
@en
Bacillus coagulans MTCC 5856 f ...... -centre, pilot clinical study.
@nl
P2093
P2860
P356
P1476
Bacillus coagulans MTCC 5856 f ...... -centre, pilot clinical study.
@en
P2093
Kalyanam Nagabhushanam
Muhammed Majeed
Shaheen Majeed
Sivakumar Arumugam
P2860
P356
10.29219/FNR.V62.1218
P50
P577
2018-07-04T00:00:00Z